Cargando…

Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model

To determine if sequential treatment with Bevacizumab (Avastin), a monoclonal, VEGF antibody that blocks angiogenesis; Saratin, a 12 kD polypeptide with anti-inflammatory and anti-thrombotic properties; and Ilomastat, a matrix metalloproteinase (MMP) inhibitor, prolongs bleb life following glaucoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Martorana, Gina M., Schaefer, Jamie L., Levine, Monica A., Lukowski, Zachary L., Min, Jeff, Meyers, Craig A., Schultz, Gregory S., Sherwood, Mark B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578880/
https://www.ncbi.nlm.nih.gov/pubmed/26394037
http://dx.doi.org/10.1371/journal.pone.0138054

Ejemplares similares